Implied Volatility Surging for ASLAN Pharmaceuticals (ASLN) Stock Options
Investors in ASLAN Pharmaceuticals Limited ASLN need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 15, 2021 $2.50 Put had some of the more...
US Oil & Gas Rig Tally Increases in 5 of the Past 6 Weeks
In its weekly release, Baker Hughes Company BKR reported an increase in the U.S. rig count from the prior week. More on the Rig Count Baker Hughes’ data, issued at the end of every week more...
Are Options Traders Betting on a Big Move in T2 Biosystems (TTOO) Stock?
Investors in T2 Biosystems, Inc. TTOO need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 21, 2022 $2.50 Call had some of the more...
BioSig Increases Installation Footprint Adding St. Elizabeth’s Medical Center to Roster of Premium Medical Institutions Utilizing the PURE EP System
The Company expands into exploration of its novel signal processing technology in physiologic pacing procedures Westport, CT, Sept. 13, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology more...
Motus GI to Present at the Oppenheimer & Co. Inc. Fall Healthcare Summit
FORT LAUDERDALE, Fla., Sept. 13, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency more...
Apollo Endosurgery to Present at Lake Street’s 5th Annual Best Ideas Growth Conference
AUSTIN, TX / ACCESSWIRE / September 13, 2021 / Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that its management team will participate more...
Oncocyte to Present New Data on DetermaIO(TM) from NeoTRIPaPDL1 Trial in Oral Presentation from Late-Breaking Abstract at ESMO 2021
Data represents first evaluation of DetermaIO in gold-standard randomized clinical trial in triple negative breast cancer IRVINE, Calif., Sept. 13, 2021 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics and monitoring company with the more...
Additional Data from Hepion Pharmaceuticals’ Phase 2a ‘AMBITION’ Trial Further Strengthens CRV431 Clinical Profile and Paves Way for Initiation of Phase 2b ‘ASCEND-NASH’ Clinical Program
Pro-C3 and ALT reductions point to anti-inflammatory and antifibrotic effects of CRV431 PK-PD models successfully predict early reductions in Pro-C3 and ALT Hepion’s proprietary AI-POWR™ and machine learning accurately predict CRV431 responders Anti-fibrotic gene expression more...
Grant & Eisenhofer P.A. Announce a Class Action Settlement Involving Purchasers of Synchronoss Common Stock
Grant & Eisenhofer P.A. Announce a Class Action Settlement Involving Purchasers of Synchronoss Common Stock Grant & Eisenhofer P.A. Announce a Class Action Settlement Involving Purchasers of Synchronoss Common Stock PR Newswire TRENTON, N.J. , more...
Nutritional High Announces Information Regarding Annual and Special Meeting of Unitholders
Toronto, Ontario–(Newsfile Corp. – September 13, 2021) – Nutritional High International Inc. (CSE: EAT) (“Nutritional High” or the “Company“) has recently mailed the meeting materials for its upcoming annual and special meeting to be held more...